Chronic Myeloid Leukemia (CML)
What is Chronic Myeloid Leukemia (CML)?
Chronic myeloid leukemia is a type of blood cancer that affects white blood cells. It starts in the bone marrow, the spongy tissue inside bones where blood cells are made. In CML, the body produces too many immature white blood cells that do not work properly.
This condition develops slowly over months or years, which is why it is called chronic. A genetic change called the Philadelphia chromosome causes bone marrow cells to grow out of control. This abnormal chromosome is not inherited from parents but develops during a person's lifetime.
CML progresses through three phases. The chronic phase is the earliest and mildest stage. The accelerated phase shows more abnormal cells and worsening symptoms. The blast phase resembles acute leukemia and requires urgent treatment. Early detection through blood testing helps catch CML in the chronic phase when treatment works best.
Symptoms
- Fatigue and weakness that does not improve with rest
- Unintended weight loss over several weeks or months
- Night sweats that soak through clothing or sheets
- Fever without infection or other clear cause
- Pain or fullness in the upper left abdomen from an enlarged spleen
- Easy bruising or bleeding from minor injuries
- Frequent infections that take longer to heal
- Bone pain or joint discomfort
- Shortness of breath during normal activities
Many people with early CML have no symptoms at all. The condition is often discovered during routine blood work for other reasons. This makes regular blood testing critical for catching CML before symptoms appear.
Concerned about Chronic Myeloid Leukemia (CML)? Check your levels.
Screen for 1,200+ health conditions
Causes and risk factors
CML happens when bone marrow cells develop a specific genetic mutation called the Philadelphia chromosome. This abnormal chromosome forms when two specific chromosomes swap genetic material. The change creates a gene that tells cells to grow without normal controls. The exact trigger for this mutation remains unknown. It is not inherited from parents and cannot be passed to children.
Risk factors for CML include exposure to high doses of radiation and being over age 60. Men develop CML slightly more often than women. Unlike many cancers, lifestyle factors like diet, exercise, and smoking do not appear to increase CML risk. Most people diagnosed with CML have no known risk factors. The condition cannot be prevented through lifestyle changes because the cause is a random genetic error in blood cells.
How it's diagnosed
CML is typically diagnosed through blood testing that reveals abnormal white blood cell counts. A complete blood count shows elevated white blood cells, often with immature cells called myelocytes and metamyelocytes present. Basophil levels above 100 cells per microliter or more than 2 percent of total white blood cells suggest CML. Platelet counts may be high in the chronic phase or low in more advanced stages.
Rite Aid's preventive health service includes blood tests that measure neutrophils, basophils, and platelet count at over 2,000 Quest Diagnostics locations. These biomarkers help identify patterns consistent with CML. If blood work shows concerning results, your doctor will order additional tests including bone marrow biopsy and genetic testing to confirm the Philadelphia chromosome. Early detection through routine blood testing leads to better treatment outcomes.
Treatment options
- Tyrosine kinase inhibitors, medications that target the abnormal protein caused by the Philadelphia chromosome
- Regular blood testing every three months to monitor treatment response and adjust medications
- Bone marrow transplant for younger patients or those who do not respond to medications
- Supportive care including medications to manage side effects and prevent infections
- Healthy diet rich in fruits, vegetables, and lean protein to support overall health during treatment
- Regular physical activity as tolerated to maintain strength and reduce fatigue
- Stress management through meditation, yoga, or counseling to support mental health
- Avoiding infections by washing hands frequently and staying away from sick people
Concerned about Chronic Myeloid Leukemia (CML)? Get tested at Rite Aid.
- Simple blood draw at your nearest lab
- Results in days, not weeks
- Share results with your doctor
Frequently asked questions
Most people with early CML have no symptoms at all. When symptoms do appear, they often include fatigue, unintended weight loss, and night sweats. Many cases are discovered during routine blood work before any symptoms develop. This is why regular blood testing is so important for early detection.
Yes, a complete blood count can show abnormal patterns that suggest CML. Elevated white blood cells with immature forms, high basophil counts, and abnormal platelet levels are key indicators. These findings prompt further testing to confirm the diagnosis. Regular blood work is the most common way CML is first discovered.
Many people with CML achieve long-term remission with tyrosine kinase inhibitor medications. Some patients can eventually stop treatment and remain in remission for years. Bone marrow transplant offers the only potential cure but carries significant risks. Most people manage CML as a chronic condition with ongoing medication and monitoring.
Without treatment, CML typically progresses from chronic phase to accelerated phase over three to five years. The blast phase can develop within months after acceleration begins. Modern medications have changed this timeline dramatically. Most people who start treatment in the chronic phase never progress to later stages.
People diagnosed with chronic phase CML and treated with tyrosine kinase inhibitors have a five-year survival rate over 90 percent. Many patients live 20 years or more with good quality of life. Survival depends on the disease phase at diagnosis and response to treatment. Early detection through blood testing improves outcomes significantly.
Bone marrow biopsy is typically needed to confirm CML after abnormal blood tests. The biopsy checks for the Philadelphia chromosome and assesses how much of the marrow is affected. Blood tests alone can suggest CML but cannot provide a definitive diagnosis. The biopsy also helps determine which phase of the disease is present.
Lifestyle changes support overall health but cannot treat CML directly. Eating a nutritious diet, staying active, and managing stress help you tolerate treatment better. Getting enough sleep and avoiding infections protect your immune system. These habits work alongside medication to help you feel better during treatment.
Most people with CML need blood tests every three months during treatment. These tests monitor whether medications are working and check for disease progression. Your doctor may order tests more often when starting new medications or if problems develop. Regular monitoring helps catch changes early so treatment can be adjusted quickly.
The Philadelphia chromosome causes bone marrow to overproduce basophils along with other white blood cells. Basophil counts above 2 percent of total white blood cells are characteristic of CML. Higher basophil levels often indicate disease progression from chronic to accelerated phase. Monitoring basophil counts helps doctors assess how well treatment is working.
CML can return if treatment is stopped too early or if cancer cells become resistant to medications. Most people need to continue treatment indefinitely to maintain remission. Some patients who achieve deep remission for several years can try stopping medication under close monitoring. Regular blood testing catches relapse early so treatment can restart quickly.